Our work shows that in cell lines with active wild-type AKT, allosteric inhibitors are more potent inducers of cell death compared to ATP-competitive inhibitors, particularly in washout experiments wherein cancer cells are not continuously exposed to these drugs. The gene discussed is AKT1; the disease is cancer.